The results suggested that LC3B was dramatically increased in the ischemic brain during the early stage of stroke but slightly increased during the late stage, which was also similar to the trend of NOX2/ROS and was inhibited by apocynin administration. The gene discussed is MAP1LC3B; the disease is Stroke.